Molecular Cancer
Molecular Cancer is published by BioMed Central as an open access journal (ISSN 1476-4598). The list article processing charge is $5,090. Typical time to publication is 16 wks. Its OpenAlex h-index is 293. Primary field: Biochemistry, Genetics and Molecular Biology. It is listed in the Directory of Open Access Journals. Fee waivers are stated as available. Figures on this page are sourced from OpenAlex and DOAJ and should be confirmed on the journal’s own site before submission.
Time to publication
16 wks
Broadly typical for the field.
h-index
293
OpenAlex citation statistic. Not a Journal Impact Factor.
2-year mean citedness
27.5
Average citations to articles from the previous two years.
What it costs to publish here
Publishing an open-access article in Molecular Cancer is listed at $5,090. The publisher also lists 4,190 EUR, 3,590 GBP. The journal reports that fee waivers are available — worth pursuing if you are funding this yourself or working from a lower-income country.
What this journal has charged over time
List price for an open-access article in Molecular Cancer, as recorded by OpenAlex for each year. The fee has risen 38% since 2019, from $3,680 to $5,090.
Publishers change list prices without notice and often apply discounts, institutional agreements or waivers. Treat this as the trend, and confirm the current figure with the journal.
Peer review and licensing
| Review model | Anonymous peer review (policy) |
|---|---|
| Licence | CC BY, CC BY-NC-ND |
| Author keeps copyright | No |
| Plagiarism screening | Yes |
| Editorial board | Published → |
| Languages | EN |
Verification checks
8 of 8 confirmed
These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.
- Listed in the Directory of Open Access JournalsDOAJ applies a documented set of inclusion criteria.Confirmed
- Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.Confirmed
- Peer review model publicly declaredAnonymous peer reviewConfirmed
- Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.Confirmed
- Screens submissions for plagiarismReported to DOAJ by the journal.Confirmed
- Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.Confirmed
- Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.Confirmed
- Still actively publishingMost recent indexed article: 2026.Confirmed
Scope
The subjects Molecular Cancer publishes most, derived from the topics assigned to its indexed articles.
Publication record
| Indexed articles | 4,006 |
|---|---|
| Total citations | 422,300 |
| i10-index | 3,379 |
| Most recent indexed article | 2026 |
| Open access since | 2002 |
| All ISSNs | 1476-4598 |
Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.